Eurofins Scientific SE
Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and human, environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, including sustainability, audit, certification, quality inspection,… Read more
Eurofins Scientific SE - Asset Resilience Ratio
Eurofins Scientific SE (ERFSF) has an Asset Resilience Ratio of 0.53% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2004–2023)
This chart shows how Eurofins Scientific SE's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Eurofins Scientific SE's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $57.70 Million | 0.53% |
| Total Liquid Assets | $57.70 Million | 0.53% |
Asset Resilience Insights
- Limited Liquidity: Eurofins Scientific SE maintains only 0.53% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Eurofins Scientific SE Industry Peers by Asset Resilience Ratio
Compare Eurofins Scientific SE's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF |
Diagnostics & Research | 1.12% |
|
Berry Genomics Co Ltd
SHE:000710 |
Diagnostics & Research | 0.45% |
|
NSN Co. Ltd
KQ:031860 |
Diagnostics & Research | 1.72% |
|
JOONGANG DNM Co.Ltd
KQ:051980 |
Diagnostics & Research | 27.26% |
|
GeneMatrix Inc
KQ:109820 |
Diagnostics & Research | 41.52% |
|
Genoray Co. Ltd
KQ:122310 |
Diagnostics & Research | 0.03% |
|
Green Cross Lab Cell Corporation
KQ:144510 |
Diagnostics & Research | 0.18% |
|
Optipharm.CO.LTD
KQ:153710 |
Diagnostics & Research | 20.73% |
Annual Asset Resilience Ratio for Eurofins Scientific SE (2004–2023)
The table below shows the annual Asset Resilience Ratio data for Eurofins Scientific SE.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | 0.04% | $4.30 Million | $10.89 Billion | -0.50pp |
| 2022-12-31 | 0.54% | $54.40 Million | $10.08 Billion | +0.35pp |
| 2021-12-31 | 0.19% | $17.40 Million | $9.33 Billion | +0.08pp |
| 2020-12-31 | 0.10% | $8.70 Million | $8.58 Billion | +0.06pp |
| 2019-12-31 | 0.05% | $3.60 Million | $7.82 Billion | -0.30pp |
| 2018-12-31 | 0.34% | $24.60 Million | $7.21 Billion | -2.29pp |
| 2017-12-31 | 2.63% | $153.29 Million | $5.83 Billion | -9.63pp |
| 2016-12-31 | 12.25% | $506.02 Million | $4.13 Billion | -3.72pp |
| 2015-12-31 | 15.98% | $591.10 Million | $3.70 Billion | +12.04pp |
| 2014-12-31 | 3.94% | $73.83 Million | $1.87 Billion | -8.19pp |
| 2013-12-31 | 12.13% | $181.62 Million | $1.50 Billion | +13.22pp |
| 2007-12-31 | -1.09% | $-6.67 Million | $612.02 Million | +0.20pp |
| 2006-12-31 | -1.29% | $-5.93 Million | $460.34 Million | -1.10pp |
| 2004-12-31 | -0.18% | $-351.00K | $190.12 Million | -- |